CrossRef Managing Metabolic DysfunctionAssociated Steatotic Liver Disease: Protocol for a Scoping Review of Patient Perceptions, Barriers, and Facilitators Sikyeong Park, Yu Shin Park, Dahye Hong, Bada Kang JMIR Research Protocols .2026
We recognize that each patients journey is unique
Consumers who receive the product typically report receiving a generic, unbranded patch with no ingredient list at all
After applying the inclusion criteria, participants were divided into three groups: 3,650 in the current prescription group, 544 in the previous prescription group, and 5,642 in the future prescription group, which served as the main comparison group
Changes to GLP-1 Medication Coverage The Centers for Medicare & Medicaid Services (CMS) has proposed changes to Medicare and Medicaid coverage for glucagon-like peptide-1 (GLP-1) medications, which are currently covered primarily for the treatment of type 2 diabetes